Compare BHVN & CNXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | CNXC |
|---|---|---|
| Founded | 2013 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2022 | 2020 |
| Metric | BHVN | CNXC |
|---|---|---|
| Price | $13.52 | $24.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | $29.08 | ★ $54.80 |
| AVG Volume (30 Days) | ★ 3.2M | 993.2K |
| Earning Date | 05-11-2026 | 03-24-2026 |
| Dividend Yield | N/A | ★ 5.79% |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $9,825,771,000.00 |
| Revenue This Year | N/A | $5.29 |
| Revenue Next Year | N/A | $2.49 |
| P/E Ratio | ★ N/A | $77.08 |
| Revenue Growth | N/A | ★ 2.15 |
| 52 Week Low | $7.48 | $22.05 |
| 52 Week High | $18.57 | $62.14 |
| Indicator | BHVN | CNXC |
|---|---|---|
| Relative Strength Index (RSI) | 69.34 | 40.46 |
| Support Level | $13.41 | $22.05 |
| Resistance Level | $13.54 | $34.64 |
| Average True Range (ATR) | 0.91 | 1.62 |
| MACD | 0.26 | -0.28 |
| Stochastic Oscillator | 81.98 | 13.57 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.